Authors: SUCIC M BOBAN D MARKOVICGLAMOCAK M BOGDANIC V NEMET D LABAR B CVORISCEC D PLAVSIC F STOOSVEIC T MRSIC M

Citation: M. Sucic et al., RELATION BETWEEN URINARY CYTOLOGY ABNORMALITIES AND CYCLOSPORINE-A THERAPY IN BONE-MARROW TRANSPLANT RECIPIENTS, Renal failure, 20(4), 1998, pp. 613-620

Authors: VRHOVAC B SARAPA N BAKRAN I HUIC M MACOLICSARINIC V FRANCETIC I WOLFCOPORDA A PLAVSIC F

Citation: B. Vrhovac et al., PHARMACOKINETIC CHANGES IN PATIENTS WITH EDEMA, Clinical pharmacokinetics, 28(5), 1995, pp. 405-418

Authors: PLAVSIC F WOLFCOPORDA A BILUSIC M LOVRIC Z MACOLIC V PURETIC Z BUBICFILIPI L VRHOVAC B

Citation: F. Plavsic et al., BIOEQUIVALENCE OF 2 ORAL CYCLOSPORINE PREPARATIONS, Arzneimittel-Forschung, 45-2(8), 1995, pp. 914-917

Authors: PLAVSIC F

Citation: F. Plavsic, CONCLUDING REMARKS, Arzneimittel-Forschung, 45-2(11), 1995, pp. 1244-1244